scispace - formally typeset
L

Limin Pan

Researcher at Chinese Academy of Sciences

Publications -  16
Citations -  3144

Limin Pan is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Drug delivery & Nanoparticle. The author has an hindex of 15, co-authored 16 publications receiving 2704 citations. Previous affiliations of Limin Pan include Seoul National University.

Papers
More filters
Journal ArticleDOI

Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.

TL;DR: TAT peptide has been employed to conjugate onto mesoporous silica nanoparticles (MSNs-TAT) with high payload for nuclear-targeted drug delivery for the first time, and may provide an effective strategy for the design and development of cell-nuclear-targeting drug delivery.
Journal ArticleDOI

NIR‐Triggered Anticancer Drug Delivery by Upconverting Nanoparticles with Integrated Azobenzene‐Modified Mesoporous Silica

TL;DR: It is highly desirable to develop NIR remote-controllable MSNs-based system which can be used both in vitro and in vivo, which, however, has not been well addressed and remains a great challenge.
Journal ArticleDOI

Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles.

TL;DR: With the nuclear drug delivery fashion, DOX-MSNs-TAT presents a promising strategy in overcoming MDR in cancer cells and improving the therapeutic index of currently available chemotherapeutics by enhancing therapeutic efficacy and reducing side effects.
Journal ArticleDOI

MSN-Mediated Sequential Vascular-to-Cell Nuclear-Targeted Drug Delivery for Efficient Tumor Regression

TL;DR: Mesoporous silica nanoparticles functionalized with peptides are developed for sequential drug delivery and a tumor in a murine xenograft model is successfully regressed.
Journal ArticleDOI

Colloidal HPMO nanoparticles: silica-etching chemistry tailoring, topological transformation, and nano-biomedical applications.

TL;DR: Colloidal hollow periodic mesoporous organosilica nanoparticles with tunable compositions and highly hybridized nanostructures are successfully synthesized by a simple, easily scale-up but versatile silica-etching chemistry (alkaline or HF etching) for their applications in nano-fabrication and nano-medicine.